Preprint / Version 1

Why is pain experienced differently in war? Understanding the placebo effect in civilian life and its consequences.

##article.authors##

  • Luke Cruz Legacy Christian Academy
  • Stephanie Njau Mentor

DOI:

https://doi.org/10.58445/rars.2720

Keywords:

Placebo effect, Anxiety and depression

Abstract

The placebo effect is a phenomenon that occurs when patients experience therapeutic benefits from treatments without any active medication. By examining the neural systems that underlie placebo responses – particularly the roles of expectation, classical conditioning, and placebo-induced activation in specific brain regions, it becomes evident that placebo effects can influence disease-relevant neurobiological systems. This paper explores the mechanisms of the placebo effect and the therapeutic potential of placebos across various conditions including pain, Parkinson’s disease, Alzheimer’s disease, anxiety/depression, and schizophrenia. We also investigate the significance of placebo responses in psychiatric conditions and their overlap with predictive coding processes. Research suggests that placebo effects could enhance clinical practices by personalizing treatments and creating psychological contexts that reduce reliance on active medication. Our findings emphasize how important it is to understand how brain systems and neurochemical mediators (e.g., dopamine) interact to mediate placebo responses. This paper underlines the need for further research into placebo mechanisms to optimize their clinical application. By harnessing the potential of the placebo effect, we can develop cost-effective and patient-centered approaches to improve outcomes in both neurological and psychiatric diseases.

References

Atlas, L. Y., & Wager, T. D. (2014). A meta-analysis of brain mechanisms of placebo analgesia: Consistent findings and unanswered questions. Placebo, 37–69.

Beecher, H. K. (1955). The powerful placebo. Journal of the American Medical Association, 159(17), 1602–1606.

Bernstein, M. H., & Brown, W. A. (2017). The placebo effect in psychiatric practice. Current Psychiatry, 16(11), 29.

Carbone, F., Djamshidian, A., Seppi, K., & Poewe, W. (2019). Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs, 33(9), 905–918. https://doi.org/10.1007/s40263-019-00661-z

Chen, J. A., Papakostas, G. I., Youn, S. J., Baer, L., Clain, A. J., Fava, M., & Mischoulon, D. (2011). Association between patient beliefs regarding assigned treatment and clinical response: Reanalysis of data from the Hypericum Depression Trial Study Group. The Journal of Clinical Psychiatry, 72(12), 1507.

Corlett, P. R., Horga, G., Fletcher, P. C., Alderson-Day, B., Schmack, K., & Powers, A. R. (2019). Hallucinations and strong priors. Trends in Cognitive Sciences, 23(2), 114–127.

De La Fuente-Fernandez, R., & Stoessl, A. J. (2002). The placebo effect in Parkinson’s disease. Trends in Neurosciences, 25(6), 302–306.

Frisaldi, E., Shaibani, A., & Benedetti, F. (2020). Understanding the mechanisms of placebo and nocebo effects. Swiss Medical Weekly, 150(3536), w20340. https://doi.org/10.4414/smw.2020.20340

Geuter, S., Koban, L., & Wager, T. D. (2017). The Cognitive Neuroscience of Placebo Effects: Concepts, Predictions, and Physiology. In Annual Review of Neuroscience (Vol. 40, Issue Volume 40, 2017, pp. 167–188). Annual Reviews. https://doi.org/10.1146/annurev-neuro-072116-031132

Hashmi, J. A., Baria, A. T., Baliki, M. N., Huang, L., Schnitzer, T. J., & Apkarian, A. V. (2012). Brain networks predicting placebo analgesia in a clinical trial for chronic back pain. Pain, 153(12), 2393–2402. https://doi.org/10.1016/j.pain.2012.08.008

Hird, E. J., Diederen, K., Leucht, S., Jensen, K. B., & McGuire, P. (2023). The placebo effect in psychosis: Why it matters and how to measure it. Biological Psychiatry Global Open Science, 3(4), 605–613.

Kaptchuk, T. J. (1998). Powerful placebo: The dark side of the randomised controlled trial. The Lancet, 351(9117), 1722–1725. https://doi.org/10.1016/S0140-6736(97)10111-8

Kelley, J. M., Kraft-Todd, G., Schapira, L., Kossowsky, J., & Riess, H. (2014). The influence of the patient-clinician relationship on healthcare outcomes: A systematic review and meta-analysis of randomized controlled trials. PloS One, 9(4), e94207.

Kirsch, I. (2019). Placebo effect in the treatment of depression and anxiety. Frontiers in Psychiatry, 10, 407.

Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2002). The functional neuroanatomy of the placebo effect. American Journal of Psychiatry, 159(5), 728–737.

Moncrieff, J., Wessely, S., Hardy, R., & Cochrane Common Mental Disorders Group. (1996). Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews, 2012(10).

Petrovic, P., Dietrich, T., Fransson, P., Andersson, J., Carlsson, K., & Ingvar, M. (2005). Placebo in emotional processing—Induced expectations of anxiety relief activate a generalized modulatory network. Neuron, 46(6), 957–969.

Schmidt, L., Braun, E. K., Wager, T. D., & Shohamy, D. (2014). Mind matters: Placebo enhances reward learning in Parkinson’s disease. Nature Neuroscience, 17(12), 1793–1797.

Wager, T. D., & Atlas, L. Y. (2015). The neuroscience of placebo effects: Connecting context, learning and health. Nature Reviews Neuroscience, 16(7), 403–418.

Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005). Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors. The Journal of Neuroscience, 25(34), 7754. https://doi.org/10.1523/JNEUROSCI.0439-05.2005

Downloads

Posted

2025-07-19

Categories